Drug intelligence / Profile preview

hypertonic saline + dextran-70

Development stage
Phase 3
Modality
Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Hypertonic saline + dextran-70 (HSD) is a combination intravenous solution used primarily for small-volume resuscitation in cases of hypovolemic shock due to trauma or burns. The formulation typically consists of 7.5% sodium chloride (hypertonic saline) and 6% dextran-70 (a high-molecular-weight polysaccharide). Hypertonic saline rapidly expands plasma volume by drawing water from the interstitial and intracellular spaces into the intravascular compartment, thereby increasing blood pressure and cardiac output[2][5][8]. Dextran-70 acts as a plasma expander by increasing oncotic pressure, prolonging the intravascular effect of the hypertonic solution[7]. This combination has been shown to restore hemodynamics more effectively than isotonic fluids in some settings and may modulate immune responses by blunting neutrophil activation and enhancing T cell function[8]. However, its benefits on long-term survival remain inconclusive based on meta-analysis data[1].

Brand names
RescueFlow
Other names
hypertonic saline-dextransodium chloride/dextran 70HSD7.5% NaCl + 6% Dextran-70

Beyond the preview

Go deeper on hypertonic saline + dextran-70.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hypertonic saline + dextran-70.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call